Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity

Toxicology and Applied Pharmacology

Volumn 150, Issue 1, 1998, Pages 158-165

  Bornheim, Lester M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CANNABIDIOL; COCAINE; CYTOCHROME P450; DEXAMETHASONE; ESTERASE; NORCOCAINE; PHENCYCLIDINE; PHENOBARBITAL;

AEROBIC METABOLISM; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER MICROSOME; LIVER TOXICITY; MALE; MOUSE; NONHUMAN;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0031834159     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8403     Document Type: Article

References (36)

1. Boelsterli, U. A., and Christian, G. (1991). Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch. Toxicol. 65, 351-360.
2. Boelsterli, U. A., Lanzotti, A., Goldlin, C., and Oertle, M. (1992). Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab. Dispos. 20, 96-101.
3. Bornheim, L. M., Borys, H. K., and Karler, R. (1981). Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time. Biochem. Pharmacol. 30, 503-507.
4. Bornheim, L. M., and Correia, M. A. (1990). Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. Mol. Pharmacol. 38, 319-326.
5. Bornheim, L. M., and Correia, M. A. (1991). Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily. Mol. Pharmacol. 40, 228-234.
6. Bornheim, L. M., Everhart, E. T., and Correia, M. A. (1993). Characterization of cannabidiol-mediated cytochrome P-450 inactivation. Biochem. Pharmacol. 45, 1323-1331.
7. Bornheim, L. M., Everhart, E. T., Li, J., and Correia, M. A. (1994). Induction and genetic regulation of cytochrome P450 by CBD. Biochem. Pharmacol. 48, 161-171.
8. Boyer, C., Ross, D., and Peterson, D. (1988). Sex and strain differences in the hepatotoxic response to acute cocaine administration in the mouse. J. Biochem. Toxicol. 3, 295-307.
9. Chan, K. W., Matthews, W. S., Saxena, S., and Wong, E. T. (1993). Frequency of cocaine and phencyclidine detection at a large urban public teaching hospital. J. Anal. Toxicol. 17, 299-303.
10. Das, G. (1993). Cardiovascular effects of cocaine abuse. J. Clin. Pharmacol. Toxicol. 31, 521-528.
11. Evans, M., and Harbison, R. (1978). Cocaine-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 45, 739-754.
12. Gillam, E., Baba, T., Kim, B., Ohmori, S., and Guengerich, F. (1993). Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123-131.
13. Halpert, J. R. (1988). Multiplicity of steroid-inducible cytochromes P-450 in rat liver microsomes. Arch. Biochem. Biophys. 263, 59-68.
14. Hiratsuka, A., Chu, T. Y. Y., Distefano, E. W., Lin, L. Y., Schmitz, D. A., and Cho, A. K. (1995). Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat. Drug Metab. Dispos. 23, 201-206.
15. Ho, I. K., and Onoda, K. I. (1981). Effect of chronic administration of phencyclidine on hepatic mixed-function oxidases in the mouse. Biochem. Pharmacol. 30, 545-547.
16. Kanel, G. C., Cassidy, W., Shuster, L., and Reynolds, T. (1990). Cocaine-induced liver cell injury, comparison of morphological features in man and in experimental models. Hepatology 11, 646-651.
17. Kim, K. Y., and Bornheim, L. M. (1997). Determination of esterase-catalyzed cocaine metabolite formation by high-performance liquid chromatography with ultraviolet detection. J. Chrom. Sci. 35, 287-290.
18. Kleber, H. (1991). Tracking the cocaine epidemic. The drug abuse warning network. J. Am. Med. Assoc. 266, 2272-2273.
19. Kloss, M. W., Rosen, G., and Rauckman, E. J. (1984). Cocaine-mediated hepatotoxicity - a critical review. Biochem. Pharmacol. 33, 169-173.
20. LeDuc, B. W., Sinclair, P. R., Shuster, L., Sinclair, J. F., Evans, J. E., and Greenblatt, D. J. (1993). Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: Role of cytochrome P-450 3A4. Pharmacology 46, 294-300.
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
22. Lubet, R. A., Mayer, R. T., Cameron, J. W., Nims, R. W., Burke, M. D., Wolff, T., and Guengerich, F. P. (1985). Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238, 43-48.
23. Marks, V., and Chapple, P. A. L. (1967). Hepatic dysfunction in heroin and cocaine users. Br. J. Addict. 62, 189-195.
24. Omura, T., and Sato, R. (1964). The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2370-2378.
25. Pasanen, M., Pellinen, P., Stenback, F., Juvonen, R., Raunio, H., and Pelkonen, O. (1995). The role of CYP enzymes in cocaine-induced liver damage. Arch. Toxicol. 69, 287-290.
26. Pellinen, P., Honkakoski, P., Stenback, F., Niemitz, M., Alhava, E., Pelkonen, O., Lang, M., and Pasanen, M. (1994). Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur. J. Pharmacol. 270, 35-43.
27. Pellinen, P., Stenback, F., Raunio, H., Pelkonen, O., and Pasanen, M. (1994). Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2 mouse. Eur. J. Pharmacol. 292, 57-65.
28. Perino, L. E., Warren, G. H., and Levine, J. S. (1987). Cocaine-induced hepatotoxicity in humans. Gastroenterology 93, 176-180.
29. Poet, T. S., McQueen, C. A., and Halpert, J. R. (1996). Participation of cytochromes P4502B and P503A in cocaine toxicity in rat hepatocytes. Drug Metab. Dispos. 24(1), 74-80.
30. Rauckman, E. J., Rosen, G. M., and Cavagnaro, J. (1981). Norcocaine nitroxide a potential hepatotoxic metabolite of cocaine. Mol. Pharmacol. 21, 458-463.
31. Rouse, B. A. (1996). Epidemiology of illicit and abused drugs in the general population, emergency department drug-related episodes, and arrestees. Clin. Chem. 42, 1330-1336.
32. Silva, M. O., Roth, D., Reddy, K. R., Fernandez, J. A., Albores-Saavedra, J., and Schiff, E. R. (1991). Hepatic dysfunction accompanying acute cocaine intoxication. J. Hepatol. 12, 312-315.
33. Simmons, D. L., McQuiddy, P., and Kasper, C. B. (1987). Induction of the hepatic mixed-function oxidase system by synthetic glucocorticoids. J. Biol. Chem. 262, 326-332.
34. Stewart, D. J., Inaba, T., Lucassen, M., and Kalow, W. (1979). Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases. Clin. Pharm. Ther. 25, 464-468.
35. Wanless, I. R., Dore, S., Gopinath, N., Tan, J., Cameron, R., Heathcote, E. J., Blendis, L. M., and Levy, G. (1990). Histopathology of cocaine hepatotoxicity-report of four patients. Gastroenterology 98, 497-501.
36. Wrighton, S. A., Ring, B. J., Watkins, P. B., and Vandenbranden, M. (1989). Identification of polymorphically expressed member of the human cytochrome P-450III family. Mol. Pharmacol. 36, 97-105.